Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2025-04-25

Clinical Trial Update: SAFE Nerve Sparing Guided by Micro-ultrasound (MUS) [Phase 3]

View source ↗

Summary

A Phase 3 trial recruiting to evaluate micro-ultrasound-guided nerve-sparing surgery for prostate cancer to preserve erectile function.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Icahn School of Medicine at Mount Sinai | Conditions: Prostate Cancer, Erectile Dysfunction | Phase 3 | Status: RECRUITING